This report describes COVID-19 vaccine effectiveness against hospitalizations for all three vaccines, with Moderna as the most effective against hospitalization.
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May–July 2021.
Since 2011, the World Trade Center (WTC) Health Program has provided health care for 9/11-related health conditions among 9/11 responders and survivors.
COVID-19 cases, emergency department visits, and hospital admissions in children and adolescents aged 0-17 years increased during June to August 2021 and in states with lower vaccination coverage.
COVID-19 case rates among students and staff in Los Angeles County transitional kindergarten through grade 12 (TK–12) schools remained low compared with the surrounding community.
For frontline workers, COVID-19 mRNA vaccines, Pfizer-BioNTech and Moderna, are effective against viral infection, but less effective during Delta variant spread.
COVID-19 vaccine effectiveness, reinfection, and hospitalization in fully, partially, and unvaccinated people during the Delta variant in Los Angeles County, California.
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
COVID-19 vaccine effectiveness against hospitalizations was stable for people who received 2 doses, and vaccines remained effective among people with risk for severe COVID-19.
COVID-19 mRNA vaccines, Pfizer-BioNTech and Moderna, are effective against infection among nursing home residents, but effectiveness declined in recent months.